Potential through simplicity: thymidine kinase-1 as a biomarker for CDK4/6 inhibitors.

MLA

McCartney, Amelia, and Luca Malorni. “Potential through Simplicity: Thymidine Kinase-1 as a Biomarker for CDK4/6 Inhibitors.” British Journal of Cancer, vol. 123, no. 2, July 2020, pp. 176–77. EBSCOhost, https://doi.org/10.1038/s41416-020-0858-y.

APA

McCartney, A., & Malorni, L. (2020). Potential through simplicity: thymidine kinase-1 as a biomarker for CDK4/6 inhibitors. British Journal of Cancer, 123(2), 176–177. https://doi.org/10.1038/s41416-020-0858-y

Chicago

McCartney, Amelia, and Luca Malorni. 2020. “Potential through Simplicity: Thymidine Kinase-1 as a Biomarker for CDK4/6 Inhibitors.” British Journal of Cancer 123 (2): 176–77. doi:10.1038/s41416-020-0858-y.